|
معدات جيانغسو يويوي الطبية & شركة التوريد المحدودة (002223.SZ) تقييم DCF
CN | Healthcare | Medical - Instruments & Supplies | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) Bundle
Take charge of your Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223SZ) valuation analysis with our state-of-the-art DCF Calculator! Preloaded with real (002223SZ) data, this Excel template enables you to adjust forecasts and assumptions to accurately calculate the intrinsic value of Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,635.9 | 6,725.7 | 6,894.3 | 7,101.7 | 7,971.7 | 8,624.0 | 9,329.6 | 10,092.9 | 10,918.8 | 11,812.1 |
| Revenue Growth, % | 0 | 45.08 | 2.51 | 3.01 | 12.25 | 8.18 | 8.18 | 8.18 | 8.18 | 8.18 |
| EBITDA | 890.7 | 2,169.7 | 1,964.3 | 2,143.0 | 3,152.8 | 2,581.8 | 2,793.1 | 3,021.6 | 3,268.8 | 3,536.3 |
| EBITDA, % | 19.21 | 32.26 | 28.49 | 30.18 | 39.55 | 29.94 | 29.94 | 29.94 | 29.94 | 29.94 |
| Depreciation | 117.0 | 214.0 | 237.9 | 254.6 | 254.8 | 274.9 | 297.4 | 321.7 | 348.1 | 376.5 |
| Depreciation, % | 2.52 | 3.18 | 3.45 | 3.59 | 3.2 | 3.19 | 3.19 | 3.19 | 3.19 | 3.19 |
| EBIT | 773.7 | 1,955.7 | 1,726.3 | 1,888.3 | 2,898.0 | 2,306.9 | 2,495.7 | 2,699.9 | 2,920.8 | 3,159.8 |
| EBIT, % | 16.69 | 29.08 | 25.04 | 26.59 | 36.35 | 26.75 | 26.75 | 26.75 | 26.75 | 26.75 |
| Total Cash | 1,563.1 | 3,390.9 | 4,674.8 | 7,352.7 | 7,215.4 | 5,906.6 | 6,389.9 | 6,912.7 | 7,478.3 | 8,090.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,245.4 | 833.7 | 783.8 | 701.4 | 533.6 | 1,159.0 | 1,253.9 | 1,356.5 | 1,467.5 | 1,587.5 |
| Account Receivables, % | 26.86 | 12.4 | 11.37 | 9.88 | 6.69 | 13.44 | 13.44 | 13.44 | 13.44 | 13.44 |
| Inventories | 926.1 | 968.4 | 1,265.5 | 1,509.0 | 1,412.3 | 1,581.6 | 1,711.0 | 1,851.0 | 2,002.4 | 2,166.3 |
| Inventories, % | 19.98 | 14.4 | 18.36 | 21.25 | 17.72 | 18.34 | 18.34 | 18.34 | 18.34 | 18.34 |
| Accounts Payable | 942.4 | 926.9 | 975.9 | 1,447.4 | 1,410.7 | 1,489.2 | 1,611.1 | 1,742.9 | 1,885.5 | 2,039.8 |
| Accounts Payable, % | 20.33 | 13.78 | 14.16 | 20.38 | 17.7 | 17.27 | 17.27 | 17.27 | 17.27 | 17.27 |
| Capital Expenditure | -440.4 | -678.9 | -284.3 | -379.4 | -132.6 | -529.9 | -573.3 | -620.2 | -670.9 | -725.8 |
| Capital Expenditure, % | -9.5 | -10.09 | -4.12 | -5.34 | -1.66 | -6.14 | -6.14 | -6.14 | -6.14 | -6.14 |
| Tax Rate, % | 15.9 | 15.9 | 15.9 | 15.9 | 15.9 | 15.9 | 15.9 | 15.9 | 15.9 | 15.9 |
| EBITAT | 673.6 | 1,704.2 | 1,503.7 | 1,634.8 | 2,437.2 | 1,993.1 | 2,156.2 | 2,332.6 | 2,523.5 | 2,730.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -878.9 | 1,593.2 | 1,259.3 | 1,820.5 | 2,787.2 | 1,021.9 | 1,778.0 | 1,923.4 | 2,080.8 | 2,251.1 |
| WACC, % | 5.35 | 5.35 | 5.35 | 5.35 | 5.34 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 7,641.8 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 2,330 | |||||||||
| Terminal Value | 126,192 | |||||||||
| Present Terminal Value | 97,260 | |||||||||
| Enterprise Value | 104,902 | |||||||||
| Net Debt | -5,602 | |||||||||
| Equity Value | 110,504 | |||||||||
| Diluted Shares Outstanding, MM | 1,002 | |||||||||
| Equity Value Per Share | 110.28 |
What You Will Receive
- Pre-Filled Financial Model: Leverage Jiangsu Yuyue Medical Equipment's actual data for accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential parameters.
- Real-Time Calculations: Instant updates show you the results as you alter inputs.
- Investor-Ready Template: A polished Excel file crafted for high-level valuation.
- Customizable and Reusable: Designed for adaptability, perfect for ongoing detailed forecasts.
Key Features
- 🔍 Real-Life Yuyue Financials: Pre-filled historical and projected data for Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223SZ).
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas compute Yuyue's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Immediately visualize Yuyue’s valuation after making adjustments.
- Scenario Analysis: Assess and compare results for different financial assumptions side-by-side.
How It Functions
- Download the Template: Gain immediate access to the Excel-based Yuyue Medical DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and more.
- Instant Calculations: The model will automatically refresh to display Jiangsu Yuyue's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the outcomes to inform your investment or financial decisions.
Why Choose This Tool for Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223SZ)?
- Designed for Industry Experts: A sophisticated tool tailored for analysts, CFOs, and consultants in the medical equipment sector.
- Comprehensive Data: Access to Jiangsu Yuyue's historical and projected financials for precise analysis.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions to inform your decisions.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Detailed, step-by-step guidance simplifies the usage process.
Who Should Use This Product?
- Healthcare Professionals: Create comprehensive and accurate valuation models for equipment procurement decisions.
- Corporate Finance Teams: Assess valuation scenarios to support strategic planning within the organization.
- Consultants and Advisors: Offer clients precise valuation insights regarding Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223SZ).
- Students and Educators: Utilize real-world data to enhance skills in financial modeling and analysis.
- Investors and Analysts: Gain insights into how medical supply companies like Jiangsu Yuyue are valued in the market.
Contents of the Template
- Pre-Filled DCF Model: Jiangsu Yuyue Medical's financial data preloaded for immediate application.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Jiangsu Yuyue's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, margins, and CAPEX to align with your scenarios.
- Financial Statements: Annual and quarterly reports to facilitate in-depth analysis.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.